If you are interested in applying to become an IA, but unsure whether you meet the requirements, you should read the IA role specification (below) and contact the Living Donor Coordinator at your nearest transplant unit in the first instance.
IAs are independent of the transplant unit, the donor and recipient. This independence allows the HTA to fulfil its role to help protect the interests of the donors by ensuring they have the opportunity to speak freely to someone not connected with the transplant unit, confirming that their wish to donate is free from any pressure to act against their will.
IAs act as a representative of the HTA to ensure the requirements of the Human Tissue Act 2004 (The HT Act) and associated Regulations are met in all cases of living organ donation.
It is an offence under the Human Tissue Act 2004 (The HT Act) for the donor to receive a reward for donating an organ/part organ.
All donors are asked to provide a signed declaration confirming there is no reward associated with the organ donation and transplantation. The declaration should be read and signed by the donor, or person consenting on the donor’s behalf either in the IAs presence or provided to the IA to submit to the HTA.
The HTA has reviewed the current template referral letter to promote greater consistency, reduce variability, and to ensure that all referral letters contain relevant donor information in line with the requirements of the Montgomery judgment.
As part of the review, we have also taken the opportunity to make some other changes.
The Human Tissue Authority (HTA), on behalf of Scottish Ministers, is responsible for assessing all living organ donation cases that take place in Scotland. The HTA also considers allogeneic donation of regenerative tissue where the donor is under 16 or an adult with incapacity in Scotland. Only once HTA approval is in place can these donations go ahead. The Human Tissue (Scotland) Act 2006 (HT Scotland Act) and The Human Organ and Tissue Live Transplants (Scotland) Regulations 2006 (the Regulations) govern living donation in Scotland.
Clinicians and transplant teams are responsible for the overall care of donors and recipients, and for assessing the medical suitability of potential donors. The Regulations require the clinician with responsibility for the donor to refer the matter to the HTA. As part of this referral specific information, certain assurances are required to ensure the legislative requirements are addressed.
The HTA regulates establishments in England, Wales and Northern Ireland that conduct licensed activities under the Human Tissue Act 2004 (HT Act). This includes establishments that remove samples from the deceased for certain purposes in the HT Act – called scheduled purposes.
The Human Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended) (the Q&S Regulations) and the Blood Safety and Quality Regulations 2005 define ‘blood component’ as ‘a therapeutic constituent of human blood (red cells, white cells, platelets and plasma) that can be prepared by various methods’.
